Concurrent Use of NSAIDs with Eliquis (Apixaban)

Quantified Bleeding Risks

The American Family Physician reports that when NSAIDs are combined with anticoagulants like apixaban, the risk of GI bleeding increases 3-6 times, with adjusted odds ratios of 3.59 (95% CI 1.58-8.17) for patients on anticoagulants 1
The Alimentary Pharmacology and Therapeutics journal notes that the combination of NSAIDs and anticoagulants can provoke bleeding from pre-existing ulcers throughout the entire GI tract, not just the stomach 2

The Clinical Gastroenterology and Hepatology journal recommends using the lowest effective NSAID dose for the shortest possible duration (ideally less than 5-7 days) 3
The Clinical Gastroenterology and Hepatology journal suggests adding proton pump inhibitor (PPI) prophylaxis to reduce GI bleeding risk by approximately 90%, though this only protects the upper GI tract 3
The Alimentary Pharmacology and Therapeutics journal considers selective COX-2 inhibitors (like celecoxib) combined with a PPI for patients at very high GI bleeding risk, though this does not eliminate cardiovascular risks 2

The Clinical Gastroenterology and Hepatology journal recommends acetaminophen (Tylenol) as the first-line analgesic when appropriate, as it does not increase bleeding risk 3

The Alimentary Pharmacology and Therapeutics journal states that NSAIDs should not be combined with apixaban in patients with active peptic ulcer disease or history of NSAID-related GI bleeding 2
The American Family Physician notes that NSAIDs should not be combined with apixaban in patients with decompensated cirrhosis or severe liver disease 1
The American Family Physician recommends avoiding NSAIDs entirely in patients with congestive heart failure 1

The American Family Physician suggests monitoring blood pressure, as NSAIDs can increase BP by an average of 5 mm Hg, potentially requiring adjustment of antihypertensive medications 1
The American Family Physician recommends assessing renal function, as approximately 2% of patients discontinue NSAIDs due to renal complications 1

The combination of anticoagulants and NSAIDs carries a significantly elevated bleeding risk, with both direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) showing increased bleeding when combined with NSAIDs, as reported by the American College of Cardiology and European Heart Journal 4, 5

The American College of Cardiology suggests considering non-pharmacologic approaches, such as physical therapy and topical agents, as an alternative to systemic NSAIDs for patients requiring anticoagulation with serious pain management needs 4

The American College of Chest Physicians guidelines explicitly recommend avoiding concomitant NSAIDs with vitamin K antagonists and using acetaminophen as first-line therapy instead (Grade 2C) 6

Use a COX-2 selective inhibitor (celecoxib) PLUS a proton pump inhibitor at the lowest effective dose for the shortest duration (ideally <5-7 days) for patients without prior GI bleeding 7, 8
Consider non-pharmacologic approaches before any systemic NSAID, such as physical therapy, topical NSAIDs, ice, compression, elevation for musculoskeletal pain, and transcutaneous electrical nerve stimulation (TENS) 6, 7